
Biologic Therapies Targeting Eosinophils: Current Status and Future Prospects
Keywords: Hypereosinophilic syndrome; Eosinophilic gastrointestinal disorders; Asthma; mAb; Mepolizumab; Reslizumab; Benralizumab; EAD; Eosinophil-associated disease; EGPA; Eosinophilic granulomatosis with polyangiitis; EMR1; Human epidermal growth factor (EGF)-l